# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The Company's ordinary share repurchases, if any, will be funded with available cash. Share repurchases may be commenced, s...
Jefferies analyst Matthew Taylor downgrades InMode (NASDAQ:INMD) from Buy to Hold and lowers the price target from $21 to $19.
Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $33 to $29.
Canaccord Genuity analyst Caitlin Cronin maintains InMode (NASDAQ:INMD) with a Hold and lowers the price target from $21 to ...
Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.